Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Botanical Formulation Derived From Birch Bark

a technology of birch bark and botanical formulation, which is applied in the directions of plant/algae/fungi/lichens, biocide, plant/algae/fungi/lichens ingredients, etc., can solve the problems of pain, reduced range of motion, and prolonged reflexive muscle contraction, so as to reduce swelling and maintain patency of abnormal neural circuit, reduce pain of tissue nerve endings, and reduce swelling

Inactive Publication Date: 2014-06-19
RADENTZ LESLIE MARIE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is a clinical formulation that has been shown to reduce abnormal neurological transmission and alleviate pain and inflammation. This formulation has been shown to disrupt malcircuitry that is associated with cytokines and neurotransmitters, leading to the cessation or reduction of pain and inflammation. It has also been shown to improve lymphatic flow and reduce swelling, which can contribute to pain reduction. The formulation mitigates extraneous neural transmission without blocking the transmission of normal sensation. This mechanism allows for the normalization and reduction of associated pain and inflammation.

Problems solved by technology

It is clinically obvious that sensory transmission is extraneously conducted to autonomic reflex arcs, resulting in intense red flushing when the patient's face is rubbed.
Inflammatory episodes of arthritis result in cytokine production responsible for extraneous neural pain transmission to muscular reflex arcs, resulting in sustained reflexive muscle contraction, stiffness, and loss of range of motion.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

examples

[0046]Over 700 patients have been treated with the inventive formulation while under the care of the inventor, a California licensed medical doctor, specialized in dermatology. The majority of patients were suffering with conditions which arose from, were impacted by or resulted in neurocutaneous malcircuitry, and which had failed standard medical treatments before receiving a topical application of the inventive solution. The only treatment failures were associated with ongoing inflammatory disorders such as an incarcerated femoral hernia, osteomyelitis, and bone fracture non-union. A more complete understanding of the present invention can be obtained by reference to the following specific examples. The examples are described solely for purposes of illustration and are not intended to limit the scope of the invention. The symptoms of patients suffering from conditions of neurocutaneous malcircuitry were mitigated by the inventive formulation as evidenced by the ratings of clinical...

example # 1

Example #1

Erythromelalgia

[0057]One of the first patients treated with the formulation of the invention suffered from Erythromelalgia, which is one of the conditions resulting from neurocutaneous malcircuitry. Erythromelalgia results in radiating progressive pain associated with autonomic system dysregulation. The pain and neural malcircuitry of erythromelalgia typically extends to the feet, and this pain is refractory to all medical and surgical treatment modalities. Typically the skin of the feet in erythromelalgia, is very inflamed, hot, and red in color, and is associated with severe recalcitrant pain. On May 16, 2006, an elderly white female, suffering with erythromelalgia, sought assistance from the treating physician and asked if there was anything that could be done to help her with her excruciating pain. Historically, the patient had suffered from multiple rheumatologic and orthopedic problems, associated with chronic severe back pain. Over many years, multiple spinal surger...

example # 2

Example #2

Herpes Zoster Infection and Post Operative Pain

[0059]An elderly white male with an active herpes zoster Infection was examined and found to be suffering from pain characterized as 15 / 10 on a pain scale of 1-10. Narcotics, steroids, capsaicin cream, and antiviral medication failed to relieve his pain. After obtaining informed consent for participation in Clinical Case Study Research, the inventive formulation was applied over the involved dermatome. Pain relief was obtained upon application, and the patient was advised to apply the inventive formulation at home twice daily. The patient states that the inventive formulation provided the only successful pain relief during his zoster infection. Application of the inventive formulation allowed the patient to finally be able to sleep at night, and the baseline pain gradually decreased with ongoing usage. After several weeks, the patient was free of zoster pain, and he discontinued application of the inventive formulation. He con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A formulation and method of mitigation of symptoms of patients suffering from a neurocutaneous pain syndrome by topical application of the formulation. The formulation is obtained by steeping the bark of a tree from the genus Betula in an aqueous acidified solution and then subsequent filtering, packaging and sterilization.

Description

BACKGROUND OF THE INVENTIONField of the Invention[0001]The present inventions deals with a botanical formulation made from the bark of a birch tree which can be used for the mitigation of conditions, diseases and disorders arising from, impacted by, or resulting in neurocutaneous malcircuitry.BACKGROUND[0002]White Birch[0003]White birch is a tree that is common to northern Europe and North America. It is known by its scientific name of Betula pendula or Betula alba. One of the chemicals isolated from birch bark is called betulin. Research suggests that betulin causes some types of tumor cells to start a process of self-destruction called apoptosis. Betulinic acid, which is made from betulin, has been studied as an anti-neoplastic agent. Betulinic acid has been reported to slow the growth of several types of tumor cells and may prove useful for treating several forms of cancer, including melanoma and certain brain cancers.[0004]In 1994, scientists at the University of North Carolina ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/88
CPCA61K36/88A61K9/0014A61K9/08A61K36/185A61P25/00
Inventor RADENTZ, LESLIE MARIE
Owner RADENTZ LESLIE MARIE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com